具有验证偏差的三类约登指数的区间估计。

IF 1.2 4区 医学 Q4 PHARMACOLOGY & PHARMACY
Shuangfei Shi, Shirui Wang, Gengsheng Qin
{"title":"具有验证偏差的三类约登指数的区间估计。","authors":"Shuangfei Shi, Shirui Wang, Gengsheng Qin","doi":"10.1080/10543406.2025.2549361","DOIUrl":null,"url":null,"abstract":"<p><p>Youden index is one of the broadly used measurements to assess the accuracy of the diagnostic test under consideration. In real medical diagnostic studies, verification of the true disease status might only be partially available due to ethical and cost considerations, and the drawbacks of gold-standard tests. Therefore, statistical evaluation of the diagnostic accuracy of a test based only on data from subjects with verified disease status is typically biased. Youden indices for the assessment of accuracy and optimal cutoff point(s) selection in diagnostic tests classifying two disease stages and three disease stages have been proposed without considering this verification bias. In this article, we develop novel confidence intervals for three-class Youden index to correct verification bias under the assumption that the true disease status, if missing, is missing at random (MAR). The proposed methods provide a comprehensive guide to dealing with the verification bias in diagnostic test accuracy studies and lead to a better choice of diagnostic tests.</p>","PeriodicalId":54870,"journal":{"name":"Journal of Biopharmaceutical Statistics","volume":" ","pages":"1-22"},"PeriodicalIF":1.2000,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Interval estimation for three-class Youden index with verification bias.\",\"authors\":\"Shuangfei Shi, Shirui Wang, Gengsheng Qin\",\"doi\":\"10.1080/10543406.2025.2549361\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Youden index is one of the broadly used measurements to assess the accuracy of the diagnostic test under consideration. In real medical diagnostic studies, verification of the true disease status might only be partially available due to ethical and cost considerations, and the drawbacks of gold-standard tests. Therefore, statistical evaluation of the diagnostic accuracy of a test based only on data from subjects with verified disease status is typically biased. Youden indices for the assessment of accuracy and optimal cutoff point(s) selection in diagnostic tests classifying two disease stages and three disease stages have been proposed without considering this verification bias. In this article, we develop novel confidence intervals for three-class Youden index to correct verification bias under the assumption that the true disease status, if missing, is missing at random (MAR). The proposed methods provide a comprehensive guide to dealing with the verification bias in diagnostic test accuracy studies and lead to a better choice of diagnostic tests.</p>\",\"PeriodicalId\":54870,\"journal\":{\"name\":\"Journal of Biopharmaceutical Statistics\",\"volume\":\" \",\"pages\":\"1-22\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-08-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Biopharmaceutical Statistics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/10543406.2025.2549361\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biopharmaceutical Statistics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10543406.2025.2549361","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

约登指数是一种广泛使用的测量来评估所考虑的诊断测试的准确性。在真正的医学诊断研究中,由于伦理和成本方面的考虑,以及金标准测试的缺点,可能只能部分地验证真实的疾病状态。因此,仅根据已证实疾病状态的受试者的数据对测试的诊断准确性进行统计评估通常是有偏差的。在不考虑这种验证偏倚的情况下,提出了用于评估两期和三期诊断试验的准确性和最佳截止点选择的约登指数。在本文中,我们建立了新的三级约登指数置信区间,以纠正在假设真实疾病状态,如果缺失,是随机缺失(MAR)的情况下的验证偏差。所提出的方法为处理诊断试验准确性研究中的验证偏差提供了全面的指导,并导致更好的诊断试验选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Interval estimation for three-class Youden index with verification bias.

Youden index is one of the broadly used measurements to assess the accuracy of the diagnostic test under consideration. In real medical diagnostic studies, verification of the true disease status might only be partially available due to ethical and cost considerations, and the drawbacks of gold-standard tests. Therefore, statistical evaluation of the diagnostic accuracy of a test based only on data from subjects with verified disease status is typically biased. Youden indices for the assessment of accuracy and optimal cutoff point(s) selection in diagnostic tests classifying two disease stages and three disease stages have been proposed without considering this verification bias. In this article, we develop novel confidence intervals for three-class Youden index to correct verification bias under the assumption that the true disease status, if missing, is missing at random (MAR). The proposed methods provide a comprehensive guide to dealing with the verification bias in diagnostic test accuracy studies and lead to a better choice of diagnostic tests.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Biopharmaceutical Statistics
Journal of Biopharmaceutical Statistics 医学-统计学与概率论
CiteScore
2.50
自引率
18.20%
发文量
71
审稿时长
6-12 weeks
期刊介绍: The Journal of Biopharmaceutical Statistics, a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to biopharmaceutical research in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers: Drug, device, and biological research and development; Drug screening and drug design; Assessment of pharmacological activity; Pharmaceutical formulation and scale-up; Preclinical safety assessment; Bioavailability, bioequivalence, and pharmacokinetics; Phase, I, II, and III clinical development including complex innovative designs; Premarket approval assessment of clinical safety; Postmarketing surveillance; Big data and artificial intelligence and applications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信